1,3-Benzodioxolylbutanamine

BDB
Clinical data
Other names	BDB; MDB; J; 3,4-Methylenedioxy-α-ethylphenethylamine; MDAEPEA; Benzodioxolylbutanamine; 3,4-Methylenedioxybutanphenamine
Routes of; administration	Oral
Drug class	Serotonin–norepinephrine releasing agent; Entactogen
Legal status
Legal status	DE: Anlage I (Authorized scientific use only); UK: Class A; US: Analogue to a Schedule I/II drug;
Identifiers
	IUPAC name 1-(1,3-benzodioxol-5-yl)butan-2-amine;
CAS Number	107447-03-0 ; HCl: 42542-07-4 ;
PubChem CID	129870;
ChemSpider	114963;
UNII	CM58WOT28Y; HCl: RFD67T622Z ;
ChEBI	CHEBI:190948;
ChEMBL	ChEMBL61507;
CompTox Dashboard (EPA)	DTXSID30910325 ;
Chemical and physical data
Formula	C11H15NO2
Molar mass	193.246 g·mol−1
3D model (JSmol)	Interactive image;
Melting point	159 to 161 °C (318 to 322 °F)
	SMILES CCC(CC1=CC2=C(C=C1)OCO2)N;
	InChI InChI=1S/C11H15NO2/c1-2-9(12)5-8-3-4-10-11(6-8)14-7-13-10/h3-4,6,9H,2,5,7,12H2,1H3; Key:VHMRXGAIDDCGDU-UHFFFAOYSA-N;
	(verify)

1,3-Benzodioxolylbutanamine (BDB), also known as 3,4-methylenedioxy-α-ethylphenethylamine or as J, is an entactogen of the phenethylamine, phenylisobutylamine, and MDxx families related to MDMA.